ALLENDALE, N.J., Nov. 20, 2025 (GLOBE NEWSWIRE) — Acuitive Technologies(R) commercializes Citregraft(TM), with its first use in a surgical case, performed on November 4th, 2025. Bone graft substitutes are used to repair defects from trauma, infection, tumor removal, and reconstructive surgery. However, poor handling, low biological activity, variable resorption rate, and inadequate integration limit their […]

(NYSE:WSR), Achievement a direct result of Company's strategic plan to remerchandise the asset to better serve the community's interests Salon Suites, Milkshake Factory and Spooner Physical Therapy among the 9 retailers who have opened over the past 36 months HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR), a neighborhood-focused owner and operator

(Other OTC:ETCG),(OTC US:ETCG),(OTC US:ETHE),(Other OTC:ETHE),(OTC US:ETH),(Other OTC:ETH),(NYSE Arca:GBTC),(OTC US:GDLC),(Other OTC:GDLC),(OTC US:LTCN),(Other OTC:LTCN),(OTC US:BCHG),(Other OTC:BCHG),(OTC US:ZCSH),(Other OTC:ZCSH),(OTC US:GXLM),(Other OTC:GXLM),(OTC US:HZEN),(Other OTC:HZEN),(OTC US:MANA),(Other OTC:MANA),(OTC US:GBAT),(Other OTC:GBAT),(OTC US:GLNK),(Other OTC:GLNK),(OTC US:FILG),(Other OTC:FILG),(OTC US:GLIV),(Other OTC:GLIV),(OTC US:DEFG),(Other OTC:DEFG),(OTC US:GSOL),(Other OTC:GSOL),(NYSE Arca:GDLC),(NYSE Arca:GSOL), STAMFORD, Conn., Nov. 20, 2025 (GLOBE NEWSWIRE) — Grayscale, the world's largest digital asset-focused investment platform*, today announced Grayscale(R)

(NYSE:FDS),(NASDAQ:FDS), NORWALK, Conn., Nov. 20, 2025 (GLOBE NEWSWIRE) — FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, today announced it will release its financial and operating results for the first quarter fiscal 2026, ending November 30, 2025, on Thursday, December 18, 2025. FactSet will host a conference call

(NASDAQ:PBM), NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced it had established a sustainable supply of high-potency iboga bark from trusted sourcing channels with deep experience in the iboga

(NasdaqGM:LOVE), STAMFORD, Conn., Nov. 20, 2025 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced that Wan Ling Martello has been appointed to the Board of Directors, effective November 20, 2025. Andrew

(Other OTC:OTCM),(OTC US:OTCM),(Other OTC:GSUI), NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Grayscale Sui Trust (SUI) (OTCQX: GSUI), one of the first investment vehicles that enables investors to gain exposure to the token underlying the SUI

(TSX:FOOD), MONTREAL, Nov. 20, 2025 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or “the Company”) (TSX: FOOD), a leading Canadian online meal solutions company, will release its financial results for the fourth quarter and year end of Fiscal 2025 on Thursday, November 27, 2025, before markets open. Neil Cuggy, President and COO, and Roslane Aouameur,

Ambow Education to Host Investor Event & HybriU(TM) Technology Showcase on December 8 GlobeNewswire November 20, 2025 CUPERTINO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) — Ambow Education Holding Ltd. (“Ambow” or the “Company”) (NYSE American: AMBO), a global innovator of AI-powered phygital (physical + digital) solutions for education, conferencing and events, today announced that it

Can-Fite's CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil GlobeNewswire November 20, 2025 ~35% of erectile dysfunction patients in a $3.2 billion market are non-responders to brands including Viagra and Cialis, and these drugs can be contraindicated for an estimated 16 million men living with diabetes CF602's unique mechanism of action enables